Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)
Support doctoral candidates in substance use research with 2-year awards to complete dissertations, aligning with NIDA priorities and encouraging diversity.
Funder: National Institutes of Health
Due Dates: May 7, 2025 (AIDS) | June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission) | September 7, 2025 (AIDS) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission) | January 7, 2026 (AIDS) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission) | May 7, 2026 (AIDS) | June 16, 2026 (New) | July 16, 2026 (Renewal/Resubmission) | September 7, 2026 (AIDS)
Funding Amounts: Up to $50,000 direct costs per year for 1–2 years; 8% indirect costs; dissertation research only.
Summary: Supports U.S. doctoral candidates in substance use/disorder research to complete dissertation projects aligned with NIDA priorities; clinical trials not allowed.
Key Information: Applicants must not propose independent clinical trials; research experience in a mentor-led trial is permitted.
Description
This opportunity provides funding for doctoral candidates to complete dissertation research projects in the field of substance use or substance use disorder (SUD). The program is designed to facilitate the entry of promising new investigators into SUD research, with a strong emphasis on projects that align with the National Institute on Drug Abuse (NIDA) strategic priorities. The award is open to candidates from a variety of academic disciplines and encourages applications from individuals who can contribute to diversifying the research workforce.
Projects may address basic, clinical (non-trial), translational, or implementation research, including but not limited to neuroscience, epidemiology, prevention, treatment, services, and health disparities related to substance use. Research must not propose an independent clinical trial, but candidates may gain experience in a clinical trial led by a mentor.
